Antidepressants & Cannabis Interactions

Pharmacist-reviewed safety guides for adults using cannabis with SSRIs, SNRIs, and other antidepressants including Lexapro, Zoloft, Prozac, Effexor, and Wellbutrin

Check Your Specific Combination →
Reviewed by Sanford A. Orloff, RPh (ret)
Peer-reviewed sources only
No login required
⚠️
Research Status: Emerging Clinical Data

Large-scale clinical trials on cannabis with most antidepressants remain limited. The interaction profiles below are based on known pharmacological mechanisms — specifically how CBD and THC affect the liver enzymes (CYP2D6, CYP3A4, CYP2C19) responsible for metabolizing most antidepressants — reviewed for clinical relevance by a licensed pharmacist.

Cannabis + Antidepressants: Quick Reference

Medication Class Common Drugs Primary Interaction Concern Level
SSRIs Lexapro, Zoloft, Prozac, Paxil, Celexa CBD inhibits CYP2D6/CYP3A4, potentially raising SSRI blood levels; serotonin pathway overlap with THC 🟡 Moderate
SNRIs Effexor, Cymbalta, Pristiq Similar CYP enzyme competition; venlafaxine (Effexor) metabolism particularly affected by CYP2D6 inhibition 🟡 Moderate
Atypical Wellbutrin, Remeron, Trintellix Wellbutrin lowers seizure threshold; cannabis at higher doses may compound this risk 🟠 Watch
TCAs Elavil, Pamelor, Tofranil Tricyclics have narrow therapeutic windows; CBD-driven enzyme inhibition raises risk of elevated blood levels 🟠 Caution
MAOIs Nardil, Parnate, Marplan MAOIs carry severe interaction risk with many substances; cannabis use should be reviewed directly with prescriber 🔴 High Priority

SSRI & Cannabis: Interaction Guides

The enzyme competition between CBD and SSRI metabolism is the most clinically consistent finding in this category — relevant for anyone using full-spectrum cannabis products alongside a daily antidepressant.

Frequently Asked Questions

Cannabis interacts with many antidepressants through shared liver enzyme pathways (CYP2D6 and CYP3A4). CBD in particular can raise blood levels of SSRIs. This does not mean the combination is always dangerous, but it does mean the interaction is real and worth understanding before combining them. Use the InteractSafe checker for your specific medication.
Serotonin syndrome is a serious condition caused by excess serotonin activity. THC has some effect on serotonin signaling, creating theoretical overlap with SSRIs and SNRIs. Full serotonin syndrome from cannabis alone is considered unlikely, but the interaction warrants attention — particularly at higher doses or with high-potency THC products.
Yes — and the distinction matters clinically. CBD is a stronger CYP enzyme inhibitor than THC, meaning it more directly affects how antidepressants are metabolized. CBD can raise blood levels of sertraline, fluoxetine, and other SSRIs. THC's primary interaction is through serotonin pathway overlap and CNS effects. Most cannabis products contain both — the ratio matters for the interaction profile.
Escitalopram is metabolized by CYP2C19 and CYP3A4. CBD inhibits CYP3A4, which can slow escitalopram's clearance and raise blood levels over time. This is considered a moderate interaction. Check the specific combination on the InteractSafe interaction checker for a full pharmacist-reviewed profile.
Sertraline is primarily metabolized via CYP2D6. CBD inhibits this enzyme, potentially raising sertraline blood levels with regular use. Combined CNS effects — sedation, mood variability — are also a consideration. The interaction is real but for most people is considered moderate, not a hard contraindication. Your prescriber should be aware of concurrent use.
Wellbutrin works differently from SSRIs — it primarily affects dopamine and norepinephrine rather than serotonin. The CYP enzyme competition concern is less pronounced. However, Wellbutrin lowers the seizure threshold, and there is evidence that high-dose cannabis may interact with this effect. The combination is not without risk and warrants discussion with your prescriber.
Yes. Edibles are metabolized through the liver — which is exactly where most antidepressant drug interactions occur. Inhaled cannabis bypasses first-pass liver metabolism and has faster, more predictable absorption. For people on daily SSRIs or SNRIs, route of administration is a meaningful variable in the interaction profile.
InteractSafe's content is reviewed by Sanford A. Orloff, RPh (ret), a retired pharmacist with over 40 years of clinical experience. All interaction profiles reference peer-reviewed pharmacological literature. InteractSafe provides safety information to support informed conversations with your healthcare provider — it does not provide medical advice or replace your prescriber.

Check Your Specific Combination

Enter your antidepressant and cannabis — get a pharmacist-reviewed interaction profile in under a minute.

Open the Interaction Checker →
This content is for informational purposes only and does not constitute medical advice.
Always consult your prescriber or pharmacist before changing how you use any medication or substance.
Reviewed by Sanford A. Orloff, RPh (ret)  ·  © 2026 InteractSafe